126 related articles for article (PubMed ID: 35757692)
1.
Lajevardi MS; Gholami E; Taheri T; Sarvnaz H; Habibzadeh S; Seyed N; Mortazavi Y; Rafati S
Front Immunol; 2022; 13():895234. PubMed ID: 35757692
[TBL] [Abstract][Full Text] [Related]
2. DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica.
Gholami E; Oliveira F; Taheri T; Seyed N; Gharibzadeh S; Gholami N; Mizbani A; Zali F; Habibzadeh S; Bakhadj DO; Meneses C; Kamyab-Hesari K; Sadeghipour A; Taslimi Y; Khadir F; Kamhawi S; Mazlomi MA; Valenzuela JG; Rafati S
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007067. PubMed ID: 30633742
[TBL] [Abstract][Full Text] [Related]
3. Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice.
Davarpanah E; Seyed N; Bahrami F; Rafati S; Safaralizadeh R; Taheri T
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007939. PubMed ID: 31899767
[TBL] [Abstract][Full Text] [Related]
4. Vector saliva in vaccines for visceral leishmaniasis: a brief encounter of high consequence?
Kamhawi S; Aslan H; Valenzuela JG
Front Public Health; 2014; 2():99. PubMed ID: 25152872
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and Efficacy of Live
Nasiri V; Dalimi A; Ghaffarifar F; Bolhassani A
Iran J Parasitol; 2016; 11(2):144-158. PubMed ID: 28096848
[TBL] [Abstract][Full Text] [Related]
6. Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.
Badirzadeh A; Taheri T; Taslimi Y; Abdossamadi Z; Heidari-Kharaji M; Gholami E; Sedaghat B; Niyyati M; Rafati S
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005774. PubMed ID: 28708893
[TBL] [Abstract][Full Text] [Related]
7. Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against
Seyed N; Peters NC; Rafati S
Front Immunol; 2018; 9():1227. PubMed ID: 29922288
[TBL] [Abstract][Full Text] [Related]
8. Expression of Concern: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica.
PLOS Neglected Tropical Diseases Editors
PLoS Negl Trop Dis; 2024 May; 18(5):e0012218. PubMed ID: 38814961
[No Abstract] [Full Text] [Related]
9. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG.
Rogers ME; Ilg T; Nikolaev AV; Ferguson MA; Bates PA
Nature; 2004 Jul; 430(6998):463-7. PubMed ID: 15269771
[TBL] [Abstract][Full Text] [Related]
10. FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis.
Carrara GMP; Stolf BS
Mem Inst Oswaldo Cruz; 2024; 119():e230182. PubMed ID: 38511814
[TBL] [Abstract][Full Text] [Related]
11. Possibilities and challenges for developing a successful vaccine for leishmaniasis.
Srivastava S; Shankar P; Mishra J; Singh S
Parasit Vectors; 2016 May; 9(1):277. PubMed ID: 27175732
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Immune Response and Protection Induced by V-ATPase Subunit F as DNA Vaccine Against
Orabi A; Maarouf M; Alammori M
Avicenna J Med Biotechnol; 2020; 12(1):9-16. PubMed ID: 32153733
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated-nonpathogenic
Seyed N; Taheri T; Rafati S
Front Microbiol; 2024; 15():1326369. PubMed ID: 38633699
[TBL] [Abstract][Full Text] [Related]
14. Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.
Saljoughian N; Taheri T; Rafati S
Front Immunol; 2014; 5():134. PubMed ID: 24744757
[TBL] [Abstract][Full Text] [Related]
15. PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice.
Katebi A; Riazi-Rad F; Varshochian R; Ajdary S
Int Immunopharmacol; 2024 Jun; 138():112538. PubMed ID: 38924865
[TBL] [Abstract][Full Text] [Related]
16. Immunization with
Avendaño-Rangel F; Agra-Duarte G; Borba PB; Moitinho V; Avila LT; da Silva LO; Viana SM; Sharma R; Gannavaram S; Nakhasi HL; de Oliveira CI
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543944
[TBL] [Abstract][Full Text] [Related]
17. Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis.
Parkash V; Jones G; Martin N; Steigmann M; Greensted E; Kaye P; Layton AM; Lacey CJ
Res Involv Engagem; 2021 May; 7(1):33. PubMed ID: 34053461
[TBL] [Abstract][Full Text] [Related]
18. Metallic nanoparticles and treatment of cutaneous leishmaniasis: A systematic review.
Guerra RO; do Carmo Neto JR; da Silva PEF; Franco PIR; Barbosa RM; de Albuquerque Martins T; Costa-Madeira J; de Assunção TSF; de Oliveira CJF; Machado JR; Silva Teixeira LA; Rodrigues WF; Júnior VR; Silva ACA; da Silva MV
J Trace Elem Med Biol; 2024 May; 83():127404. PubMed ID: 38364464
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Leishmaniasis: Update on Vaccine Development.
Whyte DC; Zufferey R
Hum Parasit Dis (Auckl); 2017; 9():. PubMed ID: 29708235
[TBL] [Abstract][Full Text] [Related]
20.
Apuzzo CF; Sullivan EC; Platt DC; Seger-Held I; Jones MA
Heliyon; 2021 Sep; 7(9):e07896. PubMed ID: 34504976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
